Competition & Peer Data API & CSV Delivery

Vyant Bio Inc's Competitiveness

Name: Vyant Bio Inc Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Vyant Bio Inc (VYNT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2022

Competitors Tracked

Publicly traded peers

Peer Group Market Share

100.00 %

vs 100.00 % a year ago

Revenue Growth Y/Y

-87.22 %

Q4 2022

Net Margin

-9,258.70 %

Q4 2022

Key Findings: Vyant Bio Inc vs Its Competitors

TTM: Trailing 12-month revenue of 1M vs -M combined for tracked competitors (100.0% combined share).
Trending: Latest-quarter revenue run-rate is decelerating (-72.4% annualized vs trailing 12 months).
Peer revenue share: Vyant Bio Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

VYNT Sales vs. its Competitors, Q4 2022

Vyant Bio Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/VYNT/competitors                    

                        https://api.csimarket.com/api/v1/companies/VYNT/relationships                    

                        https://api.csimarket.com/api/v1/companies/VYNT/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

For context: the Medical Laboratories industry grew revenue 5.7% year over year, combined, vs -87.2% for Vyant Bio Inc. Vyant Bio Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Vyant Bio Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Vyant Bio Inc	No	No	No	No
Similar Growth & Profitability (8)	0.00 % (0 of 8)	12.50 % (1 of 8)	12.50 % (1 of 8)	37.50 % (3 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

VYNT Stock Performance relative to its Competitors

VYNT Competitors (weighted) Percent change over the selected range

VYNT Stock Performance relative to Similar Growth & Profitability Competitors

VYNT Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range